These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Surfactant for the treatment of respiratory distress syndrome: selected clinical issues. Taeusch W; Alleyne C; Takahashi A; Fan B; Nguyen T; Franco G Semin Perinatol; 1988 Jul; 12(3):245-54. PubMed ID: 3041607 [No Abstract] [Full Text] [Related]
3. The development of surfactant replacement therapy and the various types of replacement surfactants. Shapiro DL Semin Perinatol; 1988 Jul; 12(3):174-9. PubMed ID: 3041602 [TBL] [Abstract][Full Text] [Related]
4. Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome. Dechant KL; Faulds D Drugs; 1991 Nov; 42(5):877-94. PubMed ID: 1723378 [TBL] [Abstract][Full Text] [Related]
5. The use of artificial surfactant (ALEC) in the prophylaxis of neonatal respiratory distress syndrome. Morley CJ Eur Respir J Suppl; 1989 Mar; 3():81s-86s. PubMed ID: 2663001 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the effect of three doses of a synthetic surfactant on the alveolar-arterial oxygen gradient in infants weighing > or = 1250 grams with respiratory distress syndrome. American Exosurf Neonatal Study Group II. Berry DD; Pramanik AK; Philips JB; Buchter DS; Kanarek KS; Easa D; Kopelman AE; Edwards K; Long W J Pediatr; 1994 Feb; 124(2):294-301. PubMed ID: 8301442 [TBL] [Abstract][Full Text] [Related]
7. Neonatal respiratory distress syndrome and surfactant therapy; a brief review. Robertson B Eur Respir J Suppl; 1989 Mar; 3():73s-76s. PubMed ID: 2662999 [TBL] [Abstract][Full Text] [Related]
8. Kinetics of surfactant in respiratory diseases of the newborn infant. Verlato G; Cogo PE; Benetti E; Gomirato S; Gucciardi A; Carnielli VP J Matern Fetal Neonatal Med; 2004 Nov; 16 Suppl 2():21-4. PubMed ID: 15590429 [TBL] [Abstract][Full Text] [Related]
11. How best to administer surfactant to VLBW infants? Kribs A Arch Dis Child Fetal Neonatal Ed; 2011 Jul; 96(4):F238-40. PubMed ID: 21444298 [No Abstract] [Full Text] [Related]
13. [Respiratory distress of the newborn infant. Use of artificial surfactant in the prevention and management of neonatal respiratory distress]. Bancalari E Rev Chil Obstet Ginecol; 1987; 52(6):359-63. PubMed ID: 3274948 [No Abstract] [Full Text] [Related]
14. Early nasal continuous positive airway pressure with or without prophylactic surfactant therapy in the premature infant with respiratory distress syndrome. Schimmel MS; Hammerman C Pediatr Radiol; 2000 Oct; 30(10):713-4. PubMed ID: 11075609 [No Abstract] [Full Text] [Related]
16. Artificial reconstituted pulmonary surfactant in prevention and treatment of respiratory distress syndrome in neonates. Jiang ZQ; Sun GM; Ma YM Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):182-4. PubMed ID: 10072978 [TBL] [Abstract][Full Text] [Related]
17. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants. Moya FR; Gadzinowski J; Bancalari E; Salinas V; Kopelman B; Bancalari A; Kornacka MK; Merritt TA; Segal R; Schaber CJ; Tsai H; Massaro J; d'Agostino R; Pediatrics; 2005 Apr; 115(4):1018-29. PubMed ID: 15805380 [TBL] [Abstract][Full Text] [Related]
18. [Surfactant in the therapy of respiratory distress syndrome]. Mlyncek M; Bánovcin P; Mlynceková D Cesk Gynekol; 1989 Aug; 54(7):516-23. PubMed ID: 2680113 [No Abstract] [Full Text] [Related]
19. [Surfactant in the therapy of idiopathic respiratory distress syndrome]. Durisová A Cesk Pediatr; 1993 Jan; 48(1):32-6. PubMed ID: 8477466 [No Abstract] [Full Text] [Related]
20. [Surfactant replacement--prevention and therapy in respiratory distress syndrome]. Schimmel MS Harefuah; 1992 Apr; 122(7):431-3. PubMed ID: 1592303 [No Abstract] [Full Text] [Related] [Next] [New Search]